We discuss recent published research on how a vitamin B3 derivative reduces new skin cancer risk, as well as other types of UV damage.
* Oral nicotinamide to reduce actinic cancer: A phase 3 double-blind randomized controlled trial.
Vitamin B3 derivative cuts risk of new skin cancers
